Diindolylmethane
DIM (3,3'-diindolylmethane) is the primary bioactive metabolite of indole-3-carbinol (I3C), found in cruciferous vegetables (broccoli, cauliflower, cabbage). DIM shifts estrogen metabolism toward the 2-hydroxylation pathway (producing 2-OHE1, a weaker, potentially protective estrogen metabolite) and away from the 16α-hydroxylation pathway (producing 16α-OHE1, a more proliferative metabolite). This 2:16 ratio shift is the primary mechanism of interest for both cancer chemoprevention and TRT estrogen management. In men on TRT, DIM is used as a "natural" estrogen modulator — not an aromatase inhibitor (it doesn't block estrogen production) but a metabolism shifter that redirects estrogen toward less potent metabolites. Clinical trials confirm DIM shifts urinary 2:16-OHE1 ratios in both men and women. It also has anti-androgenic effects at very high doses, so dosing precision matters in TRT contexts. The bioavailability of crystalline DIM is poor; microencapsulated or absorption-enhanced formulations (BioResponse DIM) are standard.
Current literature links
Evidence
No score yet
Safety
Unknown safety profile
Clinical Status
Phase II (cancer prevention); OTC as supplement
Last Sync
Not synced yet
Last Reviewed
Not reviewed yet
Dosing
Set height & weight in Settings to see your dose.
Pharmacology
Evidence Score
Plain-English Snapshot
Diindolylmethane is currently categorized as a supplement compound.
Evidence scoring has not been fully computed yet, so interpret this profile as preliminary.
Safety scoring is incomplete. Start conservatively and monitor carefully.
Core mechanism
Shifts estrogen metabolism toward 2-hydroxylation (2-OHE1) and away from 16α-hydroxylation (16α-OHE1); modulates estrogen receptor signaling without blocking aromatase
Practical Context
Strongest current signals
No indexed study summaries yet.